Proto-Oncogene Proteins. Proto Oncogene Proteins, Cellular . Proto-Oncogene Products, Cellular . Cellular Proto Oncogene Proteins . Cellular Proto-Oncogene Products . Proto Oncogene Products, Cellular . Proto Oncogene Proteins . Proto-Oncogene Proteins, Cellular . c onc Proteins . c-onc Proteins . Cellular Proto-Oncogene Proteins . Products of proto-oncogenes. Normally they do not have oncogenic or transforming properties, but are involved in the regulation or differentiation of cell growth. They often have protein kinase activity. . 1.00
Oncogene Proteins. Oncogene Product . Oncogene Protein . Product, Oncogene . Products, Oncogene . Protein, Oncogene . Proteins, Oncogene . Oncogene Products . Oncoproteins . Proteins coded by oncogenes. They include proteins resulting from the fusion of an oncogene and another gene (ONCOGENE PROTEINS, FUSION). . 0.94
Proto-Oncogene Proteins c-met. MET Proto-Oncogene, Receptor Tyrosine Kinase . MET Receptor Tyrosine Kinase . Receptor, HGF . Receptor, Hepatocyte Growth Factor . Receptor, Scatter Factor . Scatter Factor Receptor . c-Met Receptor Tyrosine Kinase . MET Proto Oncogene, Receptor Tyrosine Kinase . Proto Oncogene Proteins c met . Proto-Oncogene Proteins, met . c Met Receptor Tyrosine Kinase . c met Proteins . met Proto Oncogene Proteins . HGF Receptor . Hepatocyte Growth Factor Receptor . c-met Proteins . met Proto-Oncogene Proteins . Proto-Oncogene Protein c-met . HEPATOCYTE GROWTH FACTOR RECEPTORS . Cell surface protein-tyrosine kinase receptors for HEPATOCYTE GROWTH FACTOR. They consist of an extracellular alpha chain which is disulfide-linked to the transmembrane beta chain. The cytoplasmic portion contains the catalytic domain and sites critical for the regulation of kinase activity. Mutations in the c-met proto-oncogene are associated with papillary renal carcinoma and other neoplasia. . 0.91
Receptor, ErbB-2. Antigens, CD340 . CD340 Antigen . Metastatic Lymph Node Gene 19 Protein . Neu Receptor . Oncogene Protein HER-2 . Proto-Oncogene Proteins c-erbB-2 . Proto-oncogene Protein Neu . Proto-oncogene c-ErbB-2 . Receptor, Neu . Receptors, erbB-2 . Tyrosine Kinase-type Cell Surface Receptor HER2 . p185(c-neu) . p185erbB2 Protein . CD340 Antigens . ErbB-2 Receptor . HER 2 Proto Oncogene Protein . Neu, Proto-oncogene Protein . Oncogene Protein HER 2 . Proto Oncogene Protein HER 2 . Proto Oncogene Proteins c erbB 2 . Proto-Oncogene Protein, HER-2 . Proto-Oncogene Protein, erbB-2 . Proto-Oncogene Protein, neu . Tyrosine Kinase type Cell Surface Receptor HER2 . c erbB 2 Protein . c-ErbB-2, Proto-oncogene . erbB 2 Proto Oncogene Protein . erbB 2 Receptor Protein Tyrosine Kinase . erbB-2 Receptors . neu Proto Oncogene Protein . c-erbB-2 Protein . erbB-2 Proto-Oncogene Protein . erbB-2 Receptor Protein-Tyrosine Kinase . neu Proto-Oncogene Protein . HER-2 Proto-Oncogene Protein . Proto-Oncogene Protein p185(neu) . Proto-Oncogene Protein HER-2 . neu Receptor . Receptor, neu . C-ERBB-2 PROTEINS . ERBB-2 PROTO-ONCOGENE PROTEINS . NEU PROTO-ONCOGENE PROTEINS . NEU RECEPTORS . P185(C-NEU) . HER-2 PROTO-ONCOGENE PROTEINS . PROTO-ONCOGENE PROTEINS HER-2 . RECEPTORS, NEU . PROTO-ONCOGENE PROTEINS C-ERBB-2 . A cell surface protein-tyrosine kinase receptor that is overexpressed in a variety of ADENOCARCINOMAS. It has extensive homology to and heterodimerizes with the EGF RECEPTOR, the ERBB-3 RECEPTOR, and the ERBB-4 RECEPTOR. Activation of the erbB-2 receptor occurs through heterodimer formation with a ligand-bound erbB receptor family member. . 0.90